![USA Life Sciences Database](https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/002/920/normal/Screen_Shot_2018-09-17_at_18.38.42.png?1537205967)
RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol
USA Life Sciences Database,
Glen Rock, N.J., March 23, 2022 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc.